HIND Vyome Holdings Inc. Total Asset Value of Company
This daily price chart for Vyome Holdings Inc (HIND), with total assets at 9.10, illustrates the operations of a developer of precision treatments for skin pathologies whose success depends on patent protection and regulatory verdicts. The firm's human capital relies on immunology experts attracted by the significance of R&D projects, while financial momentum remains sluggish due to asset consolidation costs and expensive clinical trials for new drugs.
Analytical breakdowns and data insights for company ReShape Lifesciences (HIND)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Vyome Holdings Inc|HIND - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Vyome Therapeutics|HIND - Company Aggregate Debts|Debts to Book Capitalization Vyome Therapeutics|HIND - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Vyome Holdings|Interim Coverage Ratio reshapelifesciences.com
- net income and valuation multiples indicators:
Fundamental valuation:Vyome Holdings Inc
Total assets represent the aggregate volume of the company's resources, calculated reversely via ROA to assess the scale of capital and liabilities, which allows for the tracking of Vyome Holdings Inc. (HIND) material base dynamics through total asset forecasting during the development of innovative dermatological drugs and the creation of clinically effective formulas for the therapy of resistant forms of acne.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|SVRA: Cumulative Company Assets|RIGL: Aggregate Company Assets|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|Company Assets astriatx.com (ATXS)|Aggregate Company Assets enGene|Company Assets RAPT Therapeutics Inc. RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|Cumulative Company Assets Aclaris Therapeutics, Inc ACRS|Company Total Assets KYTX (Kyverna Therapeutics)|tizianalifesciences.com (TLSA) - Company Assets|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX: Company Total Assets|Avalo Therapeutics Inc - Aggregate Asset Value|Aggregate Company Assets Eledon Pharmaceuticals|Company Assets agenusbio.com AGEN|Aggregate Company Assets Climb Bio (CLYM)|Aggregate Company Assets ZURA (Zura Bio Ltd)|Company Total Assets ATYR (aTyr)|ADAG: Total Business Assets|Ikena Oncology, Inc. - Company Total Assets|Company Total Asset Base Shattuck Labs, Inc. STTK|equilliumbio.com (EQ) - Aggregate Company Assets|Total Business Assets CNTB|IMUX (Immunic Therapeutics) - Company Total Assets|ATRA - Company Balance Sheet Assets|Aggregate Company Assets InflaRx N.V. (IFRX)|Company Total Asset Base x4pharma.com|Adicet Bio, Inc. - Cumulative Company Assets|Aggregate Asset Value CELU|INmune Bio Corp - Company Total Assets|Company Total Asset Base Barinthus Biotherapeutics Corp BRNS|Kezar Life Sciences (KZR) - Aggregate Company Assets|Total Business Assets SABS|AKTX (Akari Therapeutics Plc) - Company Total Assets|Cumulative Company Assets Enlivex Therapeutics, Ltd. (ENLV)|Company Total Assets QTTB|GOVX (GeoVax Corp) - Aggregate Asset Value|Company Total Assets EDSA (Edesa Biotech, Inc.)|Company Total Asset Base ibioinc.com (IBIO)|CARM - Aggregate Company Assets|XTLB (XTL Biopharmaceuticals Ltd) - Total Business Assets|BOLT: Company Total Assets|Total Business Assets HCWB|Aggregate Company Assets Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. - Total Asset Value of Company|Company Total Assets ADTX|GRI (GRI Bio Inc) - Aggregate Asset Value|Company Total Assets XRTX (XORTX)|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Aggregate Asset Value SCNI (scinai.com)|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Asset Base TC BioPharm (Holdings) Plc (TCBP)|THRD - Aggregate Company Assets